Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Network Bio partners with Duke University on AI disease models
Network Bio has entered into a research collaboration with Duke University to develop AI models of human disease using biospecimens and clinical records.
Read Full Article
Pharma Tech
Bio-Thera gains Chinese approval for spondylitis and rheumatoid arthritis drug
China's NMPA has granted marketing authorisation for Bio-Thera Solutions’ BAT2506 to treat ankylosing spondylitis and rheumatoid arthritis.
Read Full Article
Express Pharma
CBC India partners with Indmark Paperform for square fibre drum packaging solutions
The partnership aims to introduce fibre drum packaging solutions to India's pharmaceutical and allied industries, with a focus on space utilisation, supply chain efficiency and sustainability The post CBC India partners with Indmark Paperform for square fibre drum packaging solutions appeared first on Express Pharma.
Read Full Article
Express Pharma
FOPE seeks reconsideration of proposed automatic suspension of drug manufacturing licences on NSQ reports
Federation of Pharma Entrepreneurs supports patient safety measures but calls for procedural safeguards, proportionality and an opportunity for manufacturers to present their case The post FOPE seeks reconsideration of proposed automatic suspension of drug manufacturing licences on NSQ reports appeared first on Express Pharma.
Read Full Article
Express Pharma
NPPA anti-cancer medicine price cuts to take effect from November 9
Revised MRPs reported for 1,225 formulations across 121 drugs, with estimated annual consumer savings of â‚ą3,502.31 crore The post NPPA anti-cancer medicine price cuts to take effect from November 9 appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Nov 9, 2026, 10:59 AM
Johnson & Johnson Reports P-I Data of Pasritamig + JNJ-9401 for Metastatic Castration-Resistant Prostate Cancer
Shots: Johnson & Johnson has reported first-in-human P-I data of pasritamig (KLK2xCD3) + JNJ-9401 (PSMAxCD28), dosed every 6wks., in heavily pretreated patients with mCRPC (n=144 enrolled) at SITC 2026 At the recommended regimen (n=15; median 4 prior lines), 73% achieved PSA reductions of ≥50% & 47% achieved ≥90% reductions, with 4 patients reaching undetectable PSA;… The post Johnson & Johnson Reports P-I Data of Pasritamig + JNJ-9401 for Metastatic Castration-Resistant Prostate Cancer appeared first on PharmaShots.
PharmaShots
Nov 9, 2026, 10:58 AM
bioMérieux Receives the US FDA’s 510(k) Clearance for BIOFIRE FILMARRAY GI1.1 Panels to Detect Gastrointestinal Pathogens
Shots: bioMérieux has received the US FDA’s 510(k) clearance for its BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel & GI1.1 Panel Mid, with the GI1.1 Panel also receiving CE marking under the IVDR The PCR-based panels detect 22 & 11 common gastroenteritis-causing bacteria, viruses & parasites, respectively, from a single stool sample in ~1hr. with ~2min.… The post bioMérieux Receives the US FDA’s 510(k) Clearance for BIOFIRE FILMARRAY GI1.1 Panels to Detect Gastrointestinal Pathogens appeared first on PharmaShots.
PharmaShots
Nov 9, 2026, 10:58 AM
Avanzanite Bioscience Signs an Exclusive License Agreement with ExCellThera to Commercialize Zemcelpro in Europe
Shots: Avanzanite Bioscience has signed an exclusive license agreement with Cordex Biologics, an ExCellThera company, to commercialize Zemcelpro (dorocubicel + unexpanded CD34- cells) across 32 countries incl. the EEA, UK & Switzerland, incl. potential indication expansion Avanzanite will become the EU MAH, plans to file MAAs in the UK & Switzerland and will co-fund a… The post Avanzanite Bioscience Signs an Exclusive License Agreement with ExCellThera to Commercialize Zemcelpro in Europe appeared first on PharmaShots.
PharmaShots
Nov 9, 2026, 10:57 AM
Valneva Reports P-II Trials Data of Tetravalent Shigella Vaccine S4V2
Shots: Valneva has reported positive results from 2 P-II trials of S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis: the infant trial (S4V02) in 110 infants aged 9mos. in Kenya & the controlled human infection model (CHIM) trial (S4V03) in ~120 healthy adults in the US In S4V02, S4V2 (2 dose levels; 2-dose schedule) showed… The post Valneva Reports P-II Trials Data of Tetravalent Shigella Vaccine S4V2 appeared first on PharmaShots.
PharmaShots
Nov 9, 2026, 10:56 AM
argenx to Acquire Unnatural Products for ~$1.15B to Expand Macrocyclic Peptide Capabilities
Shots: argenx has entered into a definitive agreement to acquire Unnatural Products (UNP), adding UNP’s macrocyclic peptide discovery engine to its antibody engineering capabilities for developing oral or long-acting medicines in immune-mediated diseases argenx, which already holds a minority stake in UNP, will acquire all remaining shares for $550M upfront in cash & up to… The post argenx to Acquire Unnatural Products for ~$1.15B to Expand Macrocyclic Peptide Capabilities appeared first on PharmaShots.
Pharma Tech
Nov 9, 2026, 9:46 AM
Network Bio partners with Duke University on AI disease models
Network Bio has entered into a research collaboration with Duke University to develop AI models of human disease using biospecimens and clinical records.
News
Latest industry coverage
Google News
Nov 9, 2026, 3:39 PM
Global Pharma Giants Vie for Rare Obesity Treatments - ěˇ°ě„ ěťĽëł´
Global Pharma Giants Vie for Rare Obesity TreatmentsÂ Â ěˇ°ě„ ěťĽëł´
Google News
Nov 9, 2026, 3:31 PM
Exec shares tips for pharma pricing shifts - BioXconomy
Exec shares tips for pharma pricing shifts  BioXconomy
Google News
Nov 9, 2026, 3:30 PM
Argenx buyout of peptide engine and Big Pharma favorite UNP could top $1B - BioSpace
Argenx buyout of peptide engine and Big Pharma favorite UNP could top $1BÂ Â BioSpace
Google News
Nov 9, 2026, 3:25 PM
Global biotech ingredients market to reach $4.5B by 2033, driven by sustainable and bio-based products. - Pluang
Global biotech ingredients market to reach $4.5B by 2033, driven by sustainable and bio-based products.  Pluang
Google News
Nov 9, 2026, 3:20 PM
Could new U.S. rules on China biotech investments give Europe an edge? - Pharma Voice
Could new U.S. rules on China biotech investments give Europe an edge?  Pharma Voice
Google News
Nov 9, 2026, 3:20 PM
GEA Q3 2026 slides: record margins, pharma surge offset earnings miss - Investing.com
GEA Q3 2026 slides: record margins, pharma surge offset earnings miss  Investing.com
Google News
Nov 9, 2026, 3:16 PM
Argenx buys into macrocyclic peptides with $1.15bn UNP deal - BioXconomy
Argenx buys into macrocyclic peptides with $1.15bn UNP deal  BioXconomy
Google News
Nov 9, 2026, 3:15 PM
Charles River to Acquire Frontage’s Bioanalysis, DPMK Businesses - Contract Pharma
Charles River to Acquire Frontage’s Bioanalysis, DPMK Businesses  Contract Pharma
Google News
Nov 9, 2026, 3:10 PM
PharmaBlock CMC Lifecycle Strategy Forum: Smarter Decisions Across the Drug Development Lifecycle - ACROFAN USA
PharmaBlock CMC Lifecycle Strategy Forum: Smarter Decisions Across the Drug Development Lifecycle  ACROFAN USA
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer